Search results

Technologies 5

• Regenerating heart valves
  The human heart beats approximately 35 million times every year, pumping blood into the circulation via four different heart valves. In more than four million people each year, heart valves fail for different reasons, including birth defects, age-related deteriorations and infections. At present, clinicians use either artificial prostheses or fixed animal and cadaver-sourced tissue to...
• T cell traps
  T cells, a subtype of white blood cells, play key roles in cell-mediated immunity, be it to fight infections and cancer or, when corrupted, to react against the body’s own cells in more than 80 autoimmune diseases, including type I diabetes, multiple sclerosis, rheumatoid arthritis and others. However, isolating disease-related T cells from the body...
• A broad strategy to reduce the toxicity of protein drugs
  Therapeutic variants of the natural hormone erythropoietin (EPO) which is produced in the kidney to boost the production of red blood cells are commonly used to treat anemias stemming from kidney disease, chemotherapy and other complications. However, many drugs that are based on therapeutic proteins, including EPO, often cause unwanted side effects because they not...
• Implantable cancer vaccine
  The Wyss Institute’s implantable, biodegradable cancer vaccine leverages immunotherapeutic methods and could one day help overcome melanoma, other cancers, infectious diseases, auto-immune diseases, as well as vaccinate against specific peptides, proteins, or antigens. The implant is a biodegradable polymer scaffold containing growth factors and components of each patient’s tumors. The technology was initially designed to...
• Injectable Hydrogels for Better Drug Delivery
  Wyss researchers have developed a new approach to delivering drugs and therapeutic cells using biocompatible and biodegradable hydrogels made of alginate, a naturally occurring polysaccharide from brown algae. Injectable hydrogels could greatly improve clinical ability to provide extended drug release and controlled delivery throughout the body or at targeted local sites.  The method holds promising...

News 40

View all

• Video/​Animation Introducing ‘Immuno-Materials’ to immunotherapy
  June 28, 2017
• Press Release Engineering heart valves for the many
  May 18, 2017
• Press Release Engineering human stem cells to model the kidney’s filtration barrier on a chip
  May 10, 2017

Events 1

• May 2, 2017, 4:00pm - 5:00pm Wyss Event
  
  • Add to Calendar
  • iCalendar
  • Google Calendar
  • Outlook
  • Yahoo
  Engineering Stem Cell Therapies for Heart Repair
  No therapy currently available can reduce the size of an established scar on the heart. Cell therapy aims to alter this fixed trajectory for Myocardial Infarction (MI) survivors: to intervene adverse heart remodeling, to reduce scar size, and to actually regenerate viable myocardial tissue. The last one and half decades witnessed the booming of stem... Free and open to public

Multimedia 15

View all

• 

  Video/Animation
  Wyss Focus: Immuno-Materials
  Wyss Core Faculty, Dave Mooney, explains our new Immuno-Materials Focus Area, which adds a new dimension to immunotherapy in that it harnesses materials to make treatments more efficient and effective. These material-based systems are capable of modulating immune cells and releasing them into the body where they can treat diseases.

• 

  Video/Animation
  Podocyte Cells: Kidney-on-a-Chip
  This video shows a 3-dimensional rendering of the glomerulus-on-a-chip with human stem cell-derived mature podocytes (in green) grown and differentiated in one channel (shown on top) and that extend their processes through the modeled glomerulus basement membrane towards glomerular vascular cells (in magenta) in the parallel running channel (shown on the bottom). Credit: Wyss Institute...

• 

  Audio/Podcast
  Disruptive: Mechanotherapeutics – From Drugs to Wearables
  Mechanobiology reveals insights into how the body’s physical forces and mechanics impact development, physiological health, and prevention and treatment of disease. The emerging field of Mechanotherapeutics leverages these insights towards the development of new types of pharmaceuticals, drug delivery systems, engineered tissues, and wearable therapeutic devices that leverage physical forces or target mechanical signaling pathways...

• 

  Video/Animation
  Mechanotherapeutics: From Drugs to Wearables
  The Wyss Institute’s 7th annual international symposium focused on advances in the field of Mechanobiology that have resulted in the development of new types of pharmaceuticals, drug delivery systems, engineered tissues, and wearable therapeutic devices that leverage physical forces or target mechanical signaling pathways as a core part of their mechanism of action. Organized by...

• 

  Video/Animation
  Printing Vascular Tissue
  Printing vessel vasculature is essential for sustaining functional living tissues. Until now, bioengineers have had difficulty building thick tissues, lacking a method to embed vascular networks. A 3D bioprinting method invented at the Wyss Institute and Harvard SEAS embeds a grid of vasculature into thick tissue laden with human stem cells and connective matrix. Printed...

• 

  Video/Animation
  Distributed Cell Division Counter
  Genetically engineered E. coli containing a fluorescing red protein enabled a Wyss Institute and Harvard Medical School team to analyze the population fluctuations of gut microbes by comparing proportion of “marked” to “unmarked” cells. Credit: Wyss Institute at Harvard University